A study of more than 400 adults concludes that people who undergo mitral valve surgery (between the left atrium and the left ventricle of the heart) also have much less than extreme leakage of the tricuspid valve (a section of the heart that directs blood from the right atrium to the ventricle) may additionally advantage from having both valves repaired at the equal time. The study found that simultaneous repair decreased the risk of future severe leakage of the tricuspid valve with a high mitral valve surgery success rate in India.Heart valves are responsible for regulating blood flow to and from the four chambers of the coronary heart. The valves have leaflets; thin however strong flaps of tissue that work to preserve blood from leaking back into the heart. Whilst a valve leaks, it's far called regurgitation. Leaky mitral valves are the most commonplace kind of heart valve abnormality and are most often repaired or replaced with the aid of surgical operation. In India, more than 50,000 operations are performed to repair mitral valve regurgitation annually with high life expectancy after mitral valve repair. To restore the tricuspid valve, a hoop is implanted around the valve to deal with and save you the progression of leaks and the fluid accumulation in the coronary heart this is an independent risk factor for a multiplied chance of risk of death in the long term.
“There’s a general settlement among surgeons that if there is excessive leakage of the tricuspid valve, then we should fix it,” stated the best cardiologist. “But, there was substantial uncertainty as to whether or not or no longer the tricuspid valve needs to restore on the time of mitral valve surgical treatment at the same time as the leakage is best slight or less.”
About 6.5 million Indian adults live with heart failure, a chronic, progressive condition in which the heart muscle is unable to pump enough blood to meet the body’s needs for blood and oxygen. A small percent of those patients additionally have moderate-to-intense or excessive secondary mitral regurgitation, increasing the risks and complicating the treatment of their heart failure. With this new approval, this small percentage of patients could be indicated as candidates for treatment with the MitraClip device when combined with optimal medical therapy along with high life expectancy after mitral valve repair.
The MitraClip is inserted in a minimally invasive technique thru the femoral vein inside the leg and guided into the coronary heart’s left ventricle in which it grasps the two leaflets of the mitral valve, clipping them together to reduce the backflow of blood which offers outstanding mitral valve surgery success rate in India.
India Cardiac Surgery Hospital
313/41-c, Old Rohtak Rd,
Inderlok, New Delhi,
Delhi 110035
India
International Helpline Number : +91-9370586696
Email id: enquiry@indiacardiacsurgerysite.com